New Alzheimer's drug targets tau protein in early trial
NCT ID NCT07214727
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 23 times
Summary
This early-stage study tests a new drug called ALN-5288 in 50 adults with mild Alzheimer's disease or related memory problems. The drug is given via a spinal injection and aims to reduce a harmful protein called tau in the brain. The main goals are to check safety and how the drug affects tau levels over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGMontreal, H3G 1H9, Canada
-
Clinical Trial Site
RECRUITINGOttawa, K1Z 1G3, Canada
-
Clinical Trial Site
RECRUITINGToronto, M3B 2S7, Canada
-
Clinical Trial Site
NOT_YET_RECRUITINGToronto, M5T 2S8, Canada
-
Clinical Trial Site
NOT_YET_RECRUITING's-Hertogenbosch, 5223, Netherlands
-
Clinical Trial Site
NOT_YET_RECRUITINGAmsterdam, 1081 GN, Netherlands
-
Clinical Trial Site
NOT_YET_RECRUITINGBarcelona, 08036, Spain
-
Clinical Trial Site
NOT_YET_RECRUITINGMadrid, 28040, Spain
-
Clinical Trial Site
NOT_YET_RECRUITINGSant Cugat del Vallès, 08190, Spain
-
Clinical Trial Site
NOT_YET_RECRUITINGGlasgow, G51 4TF, United Kingdom
-
Clinical Trial Site
RECRUITINGLondon, WC1N 3BG, United Kingdom
-
Clinical Trial Site
NOT_YET_RECRUITINGSheffield, S10 2JF, United Kingdom
-
Clinical Trial Site
NOT_YET_RECRUITINGSouthampton, SO16 6YD, United Kingdom
Conditions
Explore the condition pages connected to this study.